FDA flags concerns on Perrigo's birth control drug, stock falls

Perrigo

05/05/2023 16:15

** Shares of Perrigo Co  PRGO.N  down 2.8% at $35.8 
    ** U.S. Food and Drug Administration (FDA) raises concerns
on over-the-counter use of co's birth control drug, Opill
    ** FDA says efficacy of the pill in overweight individuals
is unknown as recent approvals of hormonal contraceptives
demonstrate a correlation between increasing BMI and decreasing
efficacy of hormonal contraceptives 
    ** Consumers may not correctly follow direction for use of
the pill, the U.S. health regulator added in a briefing document
    ** Including session losses, PRGO up ~6% YTD
    
    

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))